Candel Therapeutics Inc (CADL)
6.205
+0.32
(+5.35%)
USD |
NASDAQ |
Jun 28, 16:00
6.23
+0.02
(+0.40%)
After-Hours: 20:00
Candel Therapeutics Stock Buybacks (Quarterly): -0.186M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.186M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -71.34M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-71.34M
Minimum
Sep 2021
--
Maximum
Sep 2020
-11.92M
Average
--
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| Allurion Technologies Inc | -0.378M |
| AngioDynamics Inc | -- |
| Eliem Therapeutics Inc | -- |
| Macrogenics Inc | 0.00 |
| GlycoMimetics Inc | 0.00 |